Nov 10, 2016 12:26 pm UTC| Business
COPENHAGEN, Nov. 10, 2016 -- Investor News - No. 8 / 2016 Zealand informs that its management will present the company and host investor meetings at the following healthcare and biotech investor forums in November and...
Voyager Therapeutics Provides Third Quarter 2016 Investor Update
Nov 10, 2016 12:05 pm UTC| Business
VY-AADC01 program for advanced Parkinson’s disease on track for interim Phase 1b results in early December Preclinical pipeline advances along with prioritization Recent licensing deal increases access to more novel...
Nov 10, 2016 12:01 pm UTC| Business
NEW YORK, Nov. 10, 2016 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), which is developing a next-generation treatment for posttraumatic stress disorder (PTSD), will announce new results today from a...
Nov 10, 2016 12:01 pm UTC| Business
NEW YORK, Nov. 10, 2016 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), which is developing a next-generation treatment for posttraumatic stress disorder (PTSD), will announce new results today from a...
Nov 10, 2016 12:01 pm UTC| Business
Assessing next steps for blisibimod for the treatment of Systemic Lupus ErythematosusContinuing to explore blisibimod as treatment for IgA nephropathy – Phase 2 data in DecemberSollpuraTMSOLUTION phase 3 study in exocrine...
Nov 10, 2016 12:01 pm UTC| Business
Assessing next steps for blisibimod for the treatment of Systemic Lupus ErythematosusContinuing to explore blisibimod as treatment for IgA nephropathy – Phase 2 data in DecemberSollpuraTMSOLUTION phase 3 study in exocrine...
Pluristem’s $30 Million Equity Funding Approved by Innovative Medical Management Co.’s Shareholders
Nov 10, 2016 12:01 pm UTC| Business
Term sheet for investment at $1.77 per share is now bindingInnovative Medical is a publicly listed Chinese company active in the healthcare industry, and is an affiliate of ZSVC, one of the largest technology-focused VC...